Clinical Trial Update: Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated neoadjuvant sorafenib therapy prior to laser ablation for hepatocellular carcinoma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Cardarelli Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED